These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 20106344
21. [Update on current care guidelines: diagnostics, treatment and rehabilitation of multiple sclerosis]. Elovaara I, Atula S, Erälinna JP, Färkkilä M, Pirttilä T, Remes A, Ruutiainen J, Varis T, Suomalaisen Lääkäriseuran Duodecimin, Suomen Neurologisen Yhdistyksen Asettama Työryhmä. Duodecim; 2010; 126(2):199-200. PubMed ID: 20405605 [Abstract] [Full Text] [Related]
22. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients. Lebrun C, Bensa C, Debouverie M, Wiertlevski S, Brassat D, de Seze J, Rumbach L, Pelletier J, Labauge P, Brochet B, Tourbah A, Clavelou P, Club Francophone de la Sclérose en Plaques. Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085 [Abstract] [Full Text] [Related]
25. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Rovira A, Swanton J, Tintoré M, Huerga E, Barkhof F, Filippi M, Frederiksen JL, Langkilde A, Miszkiel K, Polman C, Rovaris M, Sastre-Garriga J, Miller D, Montalban X. Arch Neurol; 2009 May; 66(5):587-92. PubMed ID: 19433658 [Abstract] [Full Text] [Related]
26. Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis. Sombekke MH, Wattjes MP, Balk LJ, Nielsen JM, Vrenken H, Uitdehaag BM, Polman CH, Barkhof F. Neurology; 2013 Jan 01; 80(1):69-75. PubMed ID: 23243070 [Abstract] [Full Text] [Related]
29. [Acute posterior cord lesions in multiple sclerosis. An MRI study of the clinical course in 20 cases]. Pou Serradell A, Roquer González J, Perich Alsina X. Rev Neurol (Paris); 2000 Dec 01; 156(12):1126-35. PubMed ID: 11139729 [Abstract] [Full Text] [Related]
30. United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates. Multiple Sclerosis Study Group and the MRI Analysis Center. Wolinsky JS, Narayana PA, Johnson KP, Multiple Sclerosis Study Group and the MRI Analysis Center. Mult Scler; 2001 Feb 01; 7(1):33-41. PubMed ID: 11321192 [Abstract] [Full Text] [Related]
31. Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trial. Rovaris M, Comi G, Rocca MA, Valsasina P, Ladkani D, Pieri E, Weiss S, Shifroni G, Wolinsky JS, Filippi M, European/Canadian Glatiramer Acetate Study Group. Mult Scler; 2007 May 01; 13(4):502-8. PubMed ID: 17483532 [Abstract] [Full Text] [Related]
32. Defining interferon beta response status in multiple sclerosis patients. Rudick RA, Lee JC, Simon J, Ransohoff RM, Fisher E. Ann Neurol; 2004 Oct 01; 56(4):548-55. PubMed ID: 15389896 [Abstract] [Full Text] [Related]
38. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults. Waubant E, Chabas D, Okuda DT, Glenn O, Mowry E, Henry RG, Strober JB, Soares B, Wintermark M, Pelletier D. Arch Neurol; 2009 Aug 01; 66(8):967-71. PubMed ID: 19667217 [Abstract] [Full Text] [Related]
39. Link of the mechanisms of action of glatiramer acetate to its long-term clinical data. Moreau T. J Neurol Sci; 2009 Feb 01; 277 Suppl 1():S12-5. PubMed ID: 19200858 [Abstract] [Full Text] [Related]